GH1 and cancer: Importantly, even though adult‐onset disruption of GH axis seems to improve female lifespan, health span enhancement is still controversial as LID and L2‐Cmu mice do not show any improvements in glucose homeostasis (Mao et al., 2018), and female LID mice show decreased physical and cognitive performance, as well as no difference in cancer induced mortality when compared to controls (Ashpole et al., 2017).